Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12523 | 837 | 42.4 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
910 | 10558 | BILE ACIDS//FARNESOID X RECEPTOR//CEREBROTENDINOUS XANTHOMATOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | URSODEOXYCHOLIC ACID | Author keyword | 33 | 19% | 18% | 153 |
2 | TAUROURSODEOXYCHOLIC ACID | Author keyword | 17 | 47% | 3% | 27 |
3 | TAUROURSODEOXYCHOLATE | Author keyword | 14 | 57% | 2% | 17 |
4 | GLYCOCHENODEOXYCHOLIC ACID | Author keyword | 10 | 73% | 1% | 8 |
5 | URSODEOXYCHOLATE | Author keyword | 8 | 42% | 2% | 15 |
6 | GLYCOCHENODEOXYCHOLATE | Author keyword | 6 | 71% | 1% | 5 |
7 | HS 1200 | Author keyword | 6 | 100% | 0% | 4 |
8 | PATOGENESE MOL | Address | 4 | 15% | 3% | 27 |
9 | NUCLEAR STEROID RECEPTORS | Author keyword | 4 | 75% | 0% | 3 |
10 | UDCA | Author keyword | 3 | 22% | 2% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | URSODEOXYCHOLIC ACID | 33 | 19% | 18% | 153 | Search URSODEOXYCHOLIC+ACID | Search URSODEOXYCHOLIC+ACID |
2 | TAUROURSODEOXYCHOLIC ACID | 17 | 47% | 3% | 27 | Search TAUROURSODEOXYCHOLIC+ACID | Search TAUROURSODEOXYCHOLIC+ACID |
3 | TAUROURSODEOXYCHOLATE | 14 | 57% | 2% | 17 | Search TAUROURSODEOXYCHOLATE | Search TAUROURSODEOXYCHOLATE |
4 | GLYCOCHENODEOXYCHOLIC ACID | 10 | 73% | 1% | 8 | Search GLYCOCHENODEOXYCHOLIC+ACID | Search GLYCOCHENODEOXYCHOLIC+ACID |
5 | URSODEOXYCHOLATE | 8 | 42% | 2% | 15 | Search URSODEOXYCHOLATE | Search URSODEOXYCHOLATE |
6 | GLYCOCHENODEOXYCHOLATE | 6 | 71% | 1% | 5 | Search GLYCOCHENODEOXYCHOLATE | Search GLYCOCHENODEOXYCHOLATE |
7 | HS 1200 | 6 | 100% | 0% | 4 | Search HS+1200 | Search HS+1200 |
8 | NUCLEAR STEROID RECEPTORS | 4 | 75% | 0% | 3 | Search NUCLEAR+STEROID+RECEPTORS | Search NUCLEAR+STEROID+RECEPTORS |
9 | UDCA | 3 | 22% | 2% | 13 | Search UDCA | Search UDCA |
10 | CHENODEOXYCHOLIC ACID | 3 | 12% | 3% | 22 | Search CHENODEOXYCHOLIC+ACID | Search CHENODEOXYCHOLIC+ACID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCOCHENODEOXYCHOLATE | 41 | 100% | 2% | 15 |
2 | TAUROURSODEOXYCHOLIC ACID | 31 | 43% | 7% | 55 |
3 | HYDROPHOBIC BILE SALTS | 25 | 63% | 3% | 25 |
4 | TAUROURSODEOXYCHOLATE | 20 | 54% | 3% | 25 |
5 | NADPH OXIDASE ISOFORMS | 18 | 89% | 1% | 8 |
6 | TAUROCHOLATE INDUCED CHOLESTASIS | 15 | 77% | 1% | 10 |
7 | SALT INDUCED APOPTOSIS | 10 | 38% | 3% | 21 |
8 | SERUM LIVER ENZYMES | 8 | 56% | 1% | 10 |
9 | MEMBRANE PERTURBATION | 8 | 45% | 2% | 13 |
10 | LIPOPHILIC ANION EXCHANGER | 7 | 67% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Bile-acid-induced cell injury and protection | 2009 | 120 | 114 | 49% |
Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis | 2006 | 120 | 77 | 53% |
Bile acids: regulation of apoptosis by ursodeoxycholic acid | 2009 | 61 | 133 | 38% |
Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications | 2011 | 27 | 207 | 45% |
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' | 2001 | 166 | 113 | 39% |
Mitochondrially-mediated toxicity of bile acids | 2004 | 80 | 77 | 58% |
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease | 2008 | 26 | 60 | 38% |
Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications | 1998 | 125 | 79 | 52% |
Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis | 2010 | 13 | 23 | 39% |
Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases | 1999 | 75 | 158 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PATOGENESE MOL | 4 | 15% | 3.2% | 27 |
2 | IST SCI BIOMED S PAOLO INTERNAL MED | 2 | 67% | 0.2% | 2 |
3 | MED PEDIAT CLIN MASS SPE OMETRY | 2 | 67% | 0.2% | 2 |
4 | PEDIAT LIVER | 2 | 17% | 1.3% | 11 |
5 | PHYSIOPATHOL HEPAT | 2 | 36% | 0.5% | 4 |
6 | CLIN GASTROENTEROL HEPATOL INFECT | 2 | 43% | 0.4% | 3 |
7 | PEDIATLIVER TRANSPLANTAT PROGRAM | 2 | 43% | 0.4% | 3 |
8 | CLIN GASTROENTEROL HEPATOL INFECTIOL | 2 | 10% | 1.7% | 14 |
9 | PUSAN CANC | 1 | 19% | 0.6% | 5 |
10 | GASTROENTEROL HEPATOL INFECT | 1 | 40% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000168413 | CALCULUS BOVIS//SULFATED BILE ACID//URINARY SULFATED BILE ACID |
2 | 0.0000157046 | GALLSTONE RECURRENCE//GALLSTONE DISSOLUTION//CAS 2958 04 5 |
3 | 0.0000155489 | PRIMARY BILIARY CIRRHOSIS//ANTIMITOCHONDRIAL ANTIBODIES//RHEUMATOL ALLERGY CLIN IMMUNOL |
4 | 0.0000154213 | INTRAHEPATIC CHOLESTASIS OF PREGNANCY//PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS//ABCB11 |
5 | 0.0000142342 | BILITRANSLOCASE//CANALICULAR MEMBRANE//HEPATOCYTE COUPLETS |
6 | 0.0000140886 | OBSTRUCTIVE JAUNDICE//PREOPERATIVE BILIARY DRAINAGE//BILE DUCT LIGATION |
7 | 0.0000131098 | INTRAHEPATIC BILIARY EPITHELIUM//SCOTT WHITE DIGEST DIS//CENT TEXAS VET HLTH CARE SYST |
8 | 0.0000124428 | FECAPENTAENES//FAECAL WATER//DEOXYCHOLATE |
9 | 0.0000112787 | ARTIFICIAL CELL MICROENCAPSULATION//CONICET INQUISUR//BILE SALT MICELLES |
10 | 0.0000100720 | FARNESOID X RECEPTOR//FXR//TGR5 |